Articles in regional publications that pertain to a wide range of North Carolina-related topics.
Search Results
34 results
for "University of North Carolina at Chapel Hill--Medical schools"
Currently viewing results 1 - 15
|
PAGE
OF 3
|
Next |
Record #:
25491
Author(s):
Abstract:
Medical researchers at UNC Chapel Hill are pursuing new methods to treat diseases more quickly and efficiently. To speed up the approval process of new drugs, UNC researchers advise scientists to collaborate, communicate the implications of their work, and be open to entrepreneurial thinking.
Source:
Full Text:
Record #:
25533
Author(s):
Abstract:
The Ramphal Cardiac Surgery simulator was designed by Paul Ramphal at the University of the West Indies, and built in Chapel Hill with the help of Richard Feins, UNC professor of surgery. The simulator uses pig parts arranged like they would be in a human, and is used to train medical residents.
Source:
Full Text:
Record #:
25534
Author(s):
Abstract:
At the UNC Microbiome Core Facility, researchers have found that our intestines are full of known and unknown species that compose unique bacterial ecologies. UNC researchers share their findings on the role of bacteria in several ailments, including colitis, Crohn’s disease, irritable bowel syndrome, obesity, diabetes, cystic fibrosis, and colon cancer. They are discovering that probiotics begin to help our health when we are babies.
Source:
Full Text:
Record #:
25535
Author(s):
Abstract:
UNC researcher Carol Otey discovered the protein palladin in 1991. Otey and Teri Brenthall of the University of Washington found palladin to be the source of a genetic mutation in pancreatic cancer. Siince this discovery, Otey and UNC pancreatic researcher H.J. Kim have found nine additional forms of palladin. They believe palladin acts as a protective barrier around tumors to resist chemotheraphy drugs.
Source:
Full Text:
Record #:
25548
Author(s):
Abstract:
Professor of emergency medicine Laurence Katz started UNC’s hypothermia program in 2007, and recently formed Hibernaid, a company dedicated to creating new drugs for therapeutic hypothermia. Katz hopes to expand hypothermia programs and research to other hospitals.
Source:
Subject(s):
Full Text:
Record #:
25550
Author(s):
Abstract:
Martin Kohlmeier and Kelly Adams run UNC’s Nutrition in Medicine program and believe physicians should have a good understanding of nutrition. Their mission is to integrate nutrition education at medical schools and to provide an online curriculum to help medical students, residents, and doctors get the nutrition coursework they need.
Source:
Full Text:
Record #:
25552
Author(s):
Abstract:
J. Victor Garcia-Martinez and his lab at UNC transplanted human cells into mice to study diseases particular to humans. Their human-mouse model is the first of its kind and has enabled new possibilities for AIDS research. The Garcia-Martinez lab used the model to find that the Truvada drug can prevent HIV transmission.
Source:
Subject(s):
Full Text:
Record #:
25556
Author(s):
Abstract:
James Faber is a professor in the Department of Cell and Molecular Physiology. His lab is studying how risk for vascular disease depends on the number of collateral blood vessels a person has. So far, Faber’s lab has identified two genes that trigger collateral formation.
Source:
Full Text:
Record #:
25560
Author(s):
Abstract:
Klaus Hahn and his UNC pharmacology lab discoveredthe genetic code to make a protein that responds to light. The protein stimulates cell movement, which is a technique with the potential to repair nerve injuries, create new muscle and bone, or understand how an embryo develops.
Source:
Full Text:
Record #:
25667
Author(s):
Abstract:
UNC researchers have been researching HIV prevention and treatment, sexually transmitted disease management, and malaria vaccine development in Lilongwe, Malawi. They are using spatial-epidemiology data in vaccine trials to study communities vulnerable to mosquitos with malaria and to determine their response to treatments.
Source:
Full Text:
Record #:
25668
Author(s):
Abstract:
UNC chemists aim to decode the genome of HIV, a RNA-based virus, to model its genetic structure. They hope to decode different stages of the HIV structure and then make a movie of how it looks over its replication cycle. This could provide insight to new ideas for therapies and targeted responses to HIV and AIDS.
Source:
Full Text:
Record #:
25669
Author(s):
Abstract:
The Khmer Rouge was a radical communist group who wiped out nearly a quarter of Cambodia’s population in the late 1970s. UNC researcher, Jeffrey Sonis, is studying the remaining Khmer Rouge leaders and Cambodians testifying about the executions, forced labor, torture and rapes. His research focuses on their mental health and post-traumatic stress disorder.
Source:
Subject(s):
Full Text:
Record #:
25674
Author(s):
Abstract:
Immunologist Jon Serody studies immune cells that cause graft-versus-host disease (GVHD). When GVHD occurs, a patient’s immune system rejects bone marrow transplants, and transplanted cells invade the organs and bore holes in tissue. Serody recently found that symptoms of GVHD depend on which tissues are attacked, and the most commonly targeted organs include the skin, gastrointestinal tract, liver, and lungs.
Source:
Full Text:
Record #:
25678
Author(s):
Abstract:
Terrence Holt previously taught English and creative writing, but switched careers to become a geriatrician following his father’s death. Holt began to incorporate both careers by asking cancer patients in UNC’s chemotherapy clinic if they would like to write their personal stories. Holt is now a contributing editor and website columnist.
Source:
Full Text:
Record #:
25682
Author(s):
Abstract:
Thomas Egan and his team are testing new technology that could drastically increase the number of lungs suitable for transplant. Egan thinks it could also help surgeons to draw from a donor pool that no one has ever before considered.
Source:
Full Text: